FDA Inspection 1262436 — PureTek Corporation

PureTek Corporation — FEI 1000125324

The FDA completed an inspection of PureTek Corporation on March 7, 2025 in San Fernando, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 7, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Fernando, CA (United States)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
150521 CFR 211.122(d)Label storage access limited to authorized personnel